Craig Radnay
Orthopaedic Surgery · New York, NYNPI 1417920364
Payments from drug & device makers
Across 500 payments — averaging $735.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$252K
- Linvatec Corporation$31K
- Royal Biologics, Inc.$23K
- Restor3d, Inc.$18K
- Integra Lifesciences Corporation$17K
- In2bones USA, LLC$11K
- plus $16K from 28 others
What the payments were for
- Royalty or licence$55,18915%
- Consulting fees$246,39467%
- Speaking & faculty fees$16,7505%
- Travel & lodging$30,8328%
- Food & beverage$17,1995%
- Education$1,3400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 302 | $252,409 |
| Linvatec Corporation | 22 | $31,036 |
| Royal Biologics, Inc. | 34 | $22,625 |
| Restor3d, Inc. | 13 | $17,562 |
| Integra Lifesciences Corporation | 7 | $17,016 |
| In2bones USA, LLC | 7 | $11,168 |
| Novastep Inc. | 6 | $6,858 |
| Smith+Nephew | 23 | $3,080 |
| Gotham Surgical Solutions & Devices, Inc. | 2 | $1,232 |
| Flower Orthopedics Coporation | 6 | $863 |
| Coastal Medical Technologies LLC | 12 | $858 |
| International Life Sciences | 1 | $668 |
| Treace Medical Concepts, Inc. | 6 | $621 |
| Arthrex | 3 | $268 |
| Daiichi Sankyo Inc. | 24 | $197 |
| Bioventus LLC | 7 | $177 |
| Bone Support Inc. | 1 | $169 |
| Innovation Technologies Inc | 1 | $169 |
| Medline Industries LP | 1 | $140 |
| Johnson & Johnson(2 entities) | 4 | $89 |
| Trice Medical, Inc. | 1 | $79 |
| KCI USA, Inc. | 1 | $75 |
| Orthofix Medical, Inc. | 3 | $53 |
| DJO, LLC | 1 | $41 |
| Vericel Corporation | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| MVP Orthopedics Inc | 1 | $28 |
| Paragon 28, Inc. | 1 | $27 |
| Solventum Corporation | 1 | $25 |
| Molnlycke Health Care US, LLC | 1 | $21 |
| Curonix LLC | 1 | $18 |
| Amgen | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$139,274
- PROPHECY$115,901
- INFINITY$83,788
- INBONE$54,418
- HOFFMANN$44,653
- INVISION$42,539
- ORTHOLOC 2 LAPIFUSE$35,198
- PROSTEP MICA$20,738
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$16,952
- PANTA NAIL$16,952
- TOTAL FOOT SYSTEM$16,952
- CADENCE ANKLE REPLACEMENT SYSTEM$16,952
- COLINK PLATING SYSTEM$15,604
- SALVATION$15,225
- IBS$13,178
- CoLink$11,168
- ORTHOLOC 3DI$11,133
- Maxx BMC$9,948
- AXSOS$9,629
- T2$9,498
How this compares
$367,705 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metaxalone | 31 | $2,259 |
| Gabapentin | 162 | $982 |
| Meloxicam | 294 | $946 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 86 | $765 |
| Cephalexin | 113 | $704 |
| Tramadol Hcl | 44 | $172 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $101 |
| Cyclobenzaprine Hcl | 21 | $71 |
| Clindamycin Hcl | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$27M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$14.1M
- William RicciNew York$11.6M
- Steven HaasNew York$11.5M
- Giles ScuderiNew York$10.9M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.